Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Imaging treatment effects in depression.

Höflich A, Baldinger P, Savli M, Lanzenberger R, Kasper S.

Rev Neurosci. 2012;23(3):227-52. doi: 10.1515/revneuro-2012-0038. Review.

PMID:
22752781
2.

Molecular tools for assessing human depression by positron emission tomography.

Smith DF, Jakobsen S.

Eur Neuropsychopharmacol. 2009 Sep;19(9):611-28. doi: 10.1016/j.euroneuro.2009.04.005. Epub 2009 Jun 6. Review.

PMID:
19502013
3.

Higher pretreatment 5-HT1A receptor binding potential in bipolar disorder depression is associated with treatment remission: a naturalistic treatment pilot PET study.

Lan MJ, Hesselgrave N, Ciarleglio A, Ogden RT, Sullivan GM, Mann JJ, Parsey RV.

Synapse. 2013 Nov;67(11):773-8. doi: 10.1002/syn.21684. Epub 2013 Jun 17.

4.
5.

Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment.

Sargent PA, Kjaer KH, Bench CJ, Rabiner EA, Messa C, Meyer J, Gunn RN, Grasby PM, Cowen PJ.

Arch Gen Psychiatry. 2000 Feb;57(2):174-80.

PMID:
10665620
6.

Monoamine neurocircuitry in depression and strategies for new treatments.

Hamon M, Blier P.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:54-63. doi: 10.1016/j.pnpbp.2013.04.009. Epub 2013 Apr 19. Review.

PMID:
23602950
7.

Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.

Kasper S, Tauscher J, Willeit M, Stamenkovic M, Neumeister A, Küfferle B, Barnas C, Stastny J, Praschak-Rieder N, Pezawas L, de Zwaan M, Quiner S, Pirker W, Asenbaum S, Podreka I, Brücke T.

World J Biol Psychiatry. 2002 Jul;3(3):133-46. Review.

PMID:
12478878
8.

Neuroreceptor imaging in depression.

Savitz JB, Drevets WC.

Neurobiol Dis. 2013 Apr;52:49-65. doi: 10.1016/j.nbd.2012.06.001. Epub 2012 Jun 9. Review.

9.

Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.

Hirvonen J, Karlsson H, Kajander J, Lepola A, Markkula J, Rasi-Hakala H, Någren K, Salminen JK, Hietala J.

Int J Neuropsychopharmacol. 2008 Jun;11(4):465-76. Epub 2007 Oct 31.

PMID:
17971260
10.

Antidepressant response to aripiprazole augmentation associated with enhanced FDOPA utilization in striatum: a preliminary PET study.

Conway CR, Chibnall JT, Cumming P, Mintun MA, Gebara MA, Perantie DC, Price JL, Cornell ME, McConathy JE, Gangwani S, Sheline YI.

Psychiatry Res. 2014 Mar 30;221(3):231-9. doi: 10.1016/j.pscychresns.2014.01.003. Epub 2014 Jan 14.

11.

[Antidepressants, stressors and the serotonin 1A receptor].

Kirilly E, Gonda X, Bagdy G.

Neuropsychopharmacol Hung. 2015 Jun;17(2):81-9. Review. Hungarian.

12.

[Domino principle--monoamines in bottom-view].

Sümegi A.

Neuropsychopharmacol Hung. 2008 Jun;10(3):131-40. Review. Hungarian. Erratum in: Neuropsychopharmacol Hung. 2009 Sep;11(3):149.

13.

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.

Jensen NH, Rodriguiz RM, Caron MG, Wetsel WC, Rothman RB, Roth BL.

Neuropsychopharmacology. 2008 Sep;33(10):2303-12. Epub 2007 Dec 5.

14.

Imaging predictors of remission to anti-depressant medications in major depressive disorder.

Chi KF, Korgaonkar M, Grieve SM.

J Affect Disord. 2015 Nov 1;186:134-44. doi: 10.1016/j.jad.2015.07.002. Epub 2015 Jul 21. Review.

PMID:
26233324
15.

Antidepressant effects of insulin in streptozotocin induced diabetic mice: Modulation of brain serotonin system.

Gupta D, Kurhe Y, Radhakrishnan M.

Physiol Behav. 2014 Apr 22;129:73-8. doi: 10.1016/j.physbeh.2014.02.036. Epub 2014 Feb 28.

PMID:
24582678
16.

Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder.

Gray NA, Milak MS, DeLorenzo C, Ogden RT, Huang YY, Mann JJ, Parsey RV.

Biol Psychiatry. 2013 Jul 1;74(1):26-31. doi: 10.1016/j.biopsych.2012.11.012. Epub 2013 Jan 29.

17.

[Depression and modern neuroimaging].

Vollmert C, Tost H, Brassen S, Jatzko A, Braus DF.

Fortschr Neurol Psychiatr. 2004 Aug;72(8):435-45. Review. German.

PMID:
15305238
18.

Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review.

Bonhomme N, Esposito E.

J Clin Psychopharmacol. 1998 Dec;18(6):447-54. Review.

PMID:
9864076
19.

Molecular, Functional, and Structural Imaging of Major Depressive Disorder.

Zhang K, Zhu Y, Zhu Y, Wu S, Liu H, Zhang W, Xu C, Zhang H, Hayashi T, Tian M.

Neurosci Bull. 2016 Jun;32(3):273-85. doi: 10.1007/s12264-016-0030-0. Epub 2016 May 3. Review.

PMID:
27142698
20.

Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.

Charney DS, Menkes DB, Heninger GR.

Arch Gen Psychiatry. 1981 Oct;38(10):1160-80. Review.

PMID:
6271089

Supplemental Content

Support Center